Acinetobacter baumannii -

Acinetobacter baumannii

The Rise of a Resistant Pathogen
Buch | Hardcover
176 Seiten
2024
IntechOpen (Verlag)
978-0-85466-371-2 (ISBN)
148,35 inkl. MwSt
  • Titel nicht im Sortiment
  • Artikel merken
Notorious for its widespread drug-resistant nature, Acinetobacter baumannii is a formidable global pathogen. This book delves into numerous studies underscoring the pivotal role of A. baumannii as one of the most impactful bacteria contributing to Healthcare-Associated Infections (HAIs) within the contemporary healthcare landscape.
Acinetobacter baumannii is a formidable global pathogen notorious for its widespread drug-resistant nature. It is a major culprit in various infections, particularly targeting immunocompromised individuals in intensive care units (ICUs). A paramount concern associated with this pathogen lies in its remarkable ability to develop resistance to nearly all clinically utilized antibiotics. Furthermore, it exhibits a concerning propensity to disseminate this resistance rapidly, transcending borders and impacting healthcare facilities across diverse economic strata.
Of particular focus is the carbapenem-resistant strain of A. baumannii (CRAb). This strain has garnered the top spot on the World Health Organization's (WHO) list of pathogens, necessitating urgent attention for new treatment development. This book delves into numerous studies underscoring the pivotal role of A. baumannii as one of the most impactful bacteria contributing to Healthcare-Associated Infections (HAIs) within the contemporary healthcare landscape.
Erscheinungsdatum
Verlagsort London
Sprache englisch
Maße 175 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
ISBN-10 0-85466-371-1 / 0854663711
ISBN-13 978-0-85466-371-2 / 9780854663712
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und Erste Hilfe an Bord

von Jürgen Graf; Jochen Hinkelbein

Buch | Softcover (2024)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
39,95